Lexicon Pharmaceuticals, Inc. (LXRX) - Pendapatan perusahaan

Lambang korporat lan logo Lexicon Pharmaceuticals, Inc. (LXRX)

By adhering to laboratory environmental standards, Lexicon Pharmaceuticals (LXRX) is driving innovation, as evidenced by the company's sales dynamics. Price growth is based on the discovery of new molecular pathways to combat cardiovascular risks. The financial foundation relies on a closed-loop targeted therapy for diabetes, and the current status is 0.04, reflecting the current level of product realization.

LXRX Lexicon Corp: Pendapatan perusahaan ing interval 04.07.2022 - 15.11.2026

Rincian analitis perusahaan Lexicon Pharmaceuticals

Analisis komprehensif perusahaan:LXRX lexpharma.com
Produk asil prodhuksi Lexicon Pharma

Sales reflect the total cash inflows from the sale of goods and services over the reporting period. By analyzing the product sales trend, an investor assesses the scale of operational activity and market demand. This metric measures the effectiveness of asset commercialization before deducting all expenses. For Lexicon Pharmaceuticals (LXRX), this indicator confirms the successful market launch of Inpefa. Revenue dynamics here correlate directly with the expansion rates of the heart failure therapy.

Analisis perusahaan pesaing

Pendapatan lan volume dodolan Ascendis Pharma A/S|Pendapatan lan volume dodolan MDGL|Pendapatan perusahaan CORT (Corcept Therapeutics Inc.)|Pendapatan perusahaan rhythmtx.com RYTM|Akero Corp (AKRO) - Total pendapatan perusahaan|MTSR - Pendapatan perusahaan|MLTX: Pendapatan perusahaan|CRNX: Pendapatan lan volume dodolan|NAMS - Pendapatan reged perusahaan|Pendapatan perusahaan Soleno Therapeutics Corp|Amicus Corp (FOLD) - Pendapatan reged perusahaan|Pendapatan perusahaan 89bio.com (ETNB)|Dodolan perusahaan Agios Pharmaceuticals AGIO|Pendapatan perusahaan Structure Therapeutics Inc GPCR|MDXG - Dodolan perusahaan|rezolutebio.com - Pendapatan lan volume dodolan|MBX (MBX Biosciences Inc) - Volume dodolan perusahaan|ALT: Pendapatan lan volume dodolan|Aardvark Therapeutics Inc - Pendapatan dodolan perusahaan|SGMT (Sagimet Biosciences, Inc.) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan BioAge|Pendapatan lan volume dodolan BMEA|Dodolan perusahaan Quince Therapeutics, Inc. QNCX|Fractyl Health Inc. - Dodolan perusahaan|Pendapatan dodolan perusahaan VTVT|Agape ATP Corporation - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Pluri PLUR|SYBX: Pendapatan lan volume dodolan|Total pendapatan perusahaan Lipocine Inc. (LPCN)|MTNB (Matinas BioPharma) - Pendapatan lan volume dodolan|sprucebiosciences.com (SPRB) - Pendapatan reged perusahaan|Pendapatan perusahaan Galecto Corp (GLTO)|CTCX - Total pendapatan perusahaan|Pendapatan perusahaan Lumos Therapeutics LUMO|Organovo Corp (ONVO) - Total pendapatan perusahaan|radiuspharm.com - Pendapatan lan volume dodolan